The Hidden Risk: Why Type 1 Diabetes Carries Greater Heart and Kidney Complications Than We Thought

For years, insulin resistance was thought to be a hallmark of Type 2 diabetes. But research now shows that many people with Type 1 diabetes also struggle with insulin resistance—even those who maintain a healthy weight.

Insulin resistance means the body doesn't respond as well as it should to insulin. As a result, the pancreas has to work harder to produce more insulin to keep blood sugar stable. This extra strain can have serious effects on the body beyond blood sugar control.

Here's a striking finding: people with Type 1 diabetes experience higher rates of heart and kidney disease than people with Type 2 diabetes, even though those with Type 1 typically have fewer traditional risk factors like high blood pressure or high cholesterol.

Even more puzzling, this gap isn't fully explained by blood sugar control alone. Good glycemic management—keeping blood sugar in target range—appears to be necessary, but it may not be sufficient to prevent these serious complications.

Rising obesity rates have made this hidden burden even more serious. When obesity is combined with Type 1 diabetes and underlying insulin resistance, people develop what researchers call a 'mixed metabolic phenotype'—a combination of metabolic problems that accelerates damage to the heart and kidneys.

This mixture of factors creates a cycle that increases the speed at which end-organ complications develop, making prevention and early intervention critical.

Current treatment approaches for Type 1 diabetes focus primarily on insulin delivery and blood sugar targets. But this research suggests that broader interventions—ones that address insulin resistance directly—may be essential to prevent future heart and kidney disease.

Understanding these hidden mechanisms is the first step toward developing new strategies that could protect people with Type 1 diabetes from these serious long-term complications.

Source: Endocrinology and metabolism clinics of North America. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.